Thyroid and androgen receptor signaling are antagonized by CRYM in prostate cancer
O. Aksoy, J. Pencik, M. Hartenbach, A. A. Moazzami, M. Schlederer, T. Balber, B. Mazumder, J. Whitchurch, C. J. Roberts, M. Susani, M. Mitterhauser, R. Marculescu, G. Kramer, S. D. Turner, S. Hartenbach, , L. Kenner
This study shows that CRYM antagonizes thyroid and androgen signaling in prostate cancer and correlates with prognosis and PET imaging biomarkers.
bioRxiv · Dec 19, 2019Cancer Biology